These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9927046)

  • 1. Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac.
    Mahmoud NN; Bilinski RT; Churchill MR; Edelmann W; Kucherlapati R; Bertagnolli MM
    Cancer Res; 1999 Jan; 59(2):353-9. PubMed ID: 9927046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.
    Mahmoud NN; Boolbol SK; Bilinski RT; Martucci C; Chadburn A; Bertagnolli MM
    Cancer Res; 1997 Nov; 57(22):5045-50. PubMed ID: 9371501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
    Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
    Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.
    Dihlmann S; Gebert J; Siermann A; Herfarth C; von Knebel Doeberitz M
    Cancer Res; 1999 Apr; 59(8):1857-60. PubMed ID: 10213492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current data on the role of APC protein in the origin of colorectal cancer].
    Bonneton C; Larue L; Thiery JP
    Bull Cancer; 1997 Nov; 84(11):1053-60. PubMed ID: 9536987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
    Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
    Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
    Mahmoud NN; Boolbol SK; Dannenberg AJ; Mestre JR; Bilinski RT; Martucci C; Newmark HL; Chadburn A; Bertagnolli MM
    Carcinogenesis; 1998 Jan; 19(1):87-91. PubMed ID: 9472698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
    Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
    Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.
    Bordonaro M; Mariadason JM; Aslam F; Heerdt BG; Augenlicht LH
    Cell Growth Differ; 1999 Oct; 10(10):713-20. PubMed ID: 10547075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer.
    Javid SH; Moran AE; Carothers AM; Redston M; Bertagnolli MM
    Carcinogenesis; 2005 Mar; 26(3):587-95. PubMed ID: 15579483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
    Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J
    Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
    Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation.
    Bläker H; Scholten M; Sutter C; Otto HF; Penzel R
    Am J Clin Pathol; 2003 Sep; 120(3):418-23. PubMed ID: 14502807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence re: N.N. Mahmoud et al., Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. Cancer Res., 59: 353-359, 1999.
    Augenlicht LH
    Cancer Res; 1999 Nov; 59(22):5856-7. PubMed ID: 10582710
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
    Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM
    Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.